Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zdravko Mitrovic

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|June 20, 2012
Biological prognostic markers in diffuse large B-cell lymphomaAnamarija M Perry, Zdravko Mitrovic, Wing C Chan
Clinical Lymphoma & Myeloma|May 2, 2009
CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphomaZdravko Mitrovic, Ivana Ilic, Marin Nola, et al.
Leukemia & Lymphoma|December 18, 2019
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemiaVlatko Pejsa, Marko Lucijanic, Anamarija Vrkljan Vuk, et al.
International Journal of Hematology|October 13, 2017
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosisMarko Lucijanic, Zdravko Mitrovic, David Cicic, et al.
Cancers|February 10, 2024
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre ExperienceLea Galunic Bilic, Fedor Santek, Zdravko Mitrovic, et al.
La Radiologia Medica|March 15, 2023
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experienceLea Galunic Bilic, Fedor Santek, Josip J Grah, et al.
European Journal of Haematology|March 21, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic, et al.
British Journal of Haematology|April 27, 2013
CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphomaZdravko Mitrovic, Javeed Iqbal, Kai Fu, et al.
American Journal of Hematology|April 11, 2012
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma ProjectZdravko Mitrovic, Anamarija M Perry, Junji Suzumiya, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Control : Journal of the Moffitt Cancer Center|June 20, 2012
Biological prognostic markers in diffuse large B-cell lymphomaAnamarija M Perry, Zdravko Mitrovic, Wing C Chan
Clinical Lymphoma & Myeloma|May 2, 2009
CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphomaZdravko Mitrovic, Ivana Ilic, Marin Nola, et al.
Leukemia & Lymphoma|December 18, 2019
Prolonged methylprednisolone premedication prior to obinutuzumab in patients with chronic lymphocytic leukemiaVlatko Pejsa, Marko Lucijanic, Anamarija Vrkljan Vuk, et al.
International Journal of Hematology|October 13, 2017
Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosisMarko Lucijanic, Zdravko Mitrovic, David Cicic, et al.
Cancers|February 10, 2024
Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins's Lymphoma Patients-A Single Centre ExperienceLea Galunic Bilic, Fedor Santek, Zdravko Mitrovic, et al.
La Radiologia Medica|March 15, 2023
Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experienceLea Galunic Bilic, Fedor Santek, Josip J Grah, et al.
European Journal of Haematology|March 21, 2023
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem)Zdravko Mitrovic, Dino Dujmovic, Ozren Jaksic, et al.
British Journal of Haematology|April 27, 2013
CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphomaZdravko Mitrovic, Javeed Iqbal, Kai Fu, et al.
American Journal of Hematology|April 11, 2012
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma ProjectZdravko Mitrovic, Anamarija M Perry, Junji Suzumiya, et al.
Pageof 1